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Abstract
Introduction. Granulomatosis Wegener is anti-neutrophil
cytoplasmic antibodies (ANCAs)-associated systemic vasculi-
tis of unknown etiology. It is manifested as granulomatous
necrotizing inflammation of the upper and lower parts of the
respiratory tract, glomerulonephritis and systemic vasculitis
involving most frequently the skin and oral mucous mem-
brane. Sera markers of this disease are c-ANCA and p-
ANCA. Case report. We presented a female patient aged 52
years with purpuric spots that had appeared on the lower legs
ten months before admission to our hospital. The disease ran
an aggressive course, and a month before admission hemor-
rhagic bullae, skin ulcers, hoarseness, dyspnea, generalized
arthralgia, fatigue and fever had rapidly developed. Histo-
pathological examination of a skin sample revealed necrotiz-
ing vasculitis, so that sera markers concentrations were ele-
vated (c-ANCA, p-ANCA). There was a perforation of the
nasal septum found on rhinoscopy. During hospitalization
acute abdominal pain occurred, a possible tumor in the small
intestine and possible granulomas in the liver were seen by
multislice computed tomography (MSCT) examination, with
normal findings on the lungs and kidneys. The treatment
started with methylprednisolone: 500 mg/d i.v. infusion for
consecutive 3 days, then 60 mg/d. On exploratory laparot-
omy small bowel perforation and diffuse peritonitis were
found. Unstable in the postoperative period, the patient died
on the day 12 of hospitalization. Conclusion. The reported
patient was with fulminant Wegener’s granulomatosis, domi-
nantly with skin changes and with gastrointestinal manifesta-
tion. This case accents the need for rapid systemic clinical
evaluation in a severely ill patient with unclear diagnosis.
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Apstrakt
Uvod. Wegener-ova granulomatoza je sistemski vaskulitis
nepoznate etiologije povezan sa prisustvom antineutrofil-
nih citoplazma antigen antitela (ANCA). Manifestuje se
nekrotizujuýom granulomskom upalom gornjih i donjih
delova disajnih puteva, glomerulonefritisom i sistemskim
vaskulitisom koji zahvata kožu i sluznicu usne duplje. Se-
romarkeri oboljenja su c-ANCA i p-ANCA. Prikaz bole-
snika. Prikazana je bolesnica stara 52 godine, kojoj su se
10 meseci pre prijema u Kliniku pojavile purpuriÿne mrlje
na potkolenicama, a mesec dana pre prijema hemoragiÿke
bule i ulceracije na koži, uz promuklost, dispnoju, bol u
zglobovima, malaksalost i febrilnost. Histopatološkim pre-
gledom uzorka izmenjene kože verifikovan je nekrotizujuýi
vaskulitis, a koncentracije seromarkera su bile povišene: c-
ANCA 18 IU/mL; p-ANCA 30 IU/mL. Uoÿena je i per-
foracija nosnog septuma. Tokom hospitalizacije javio se i
bol u trbuhu, a pregledom multislajsnom kompjuterizova-
nom tomografijom (MSCT) viĀen je moguýi tumor na
tankom crevu, kao i moguýi granulomi u jetri, uz uredan
nalaz na pluýima i bubrezima. Zapoÿeto je leÿenje metil-
prednizolonom 500 mg/d iv infuzijom tokom 3 dana, po-
tom 60 mg/d. Eksplorativnom laparotomijom naĀena je
perforacija tankog creva uz difuzni peritonitis. Nestabilna
u postoperativnom toku, bolesnica je preminula 12. dana
hospitalizacije  Zakljuÿak. Prikazana je bolesnica sa
Wegener-ovom granulomatozom fulminantnog toka sa
dominantnim promenama na koži i gastrointestinalnom
traktu. Ovaj sluÿaj naglašava potrebu za brzom sistem-
skom kliniÿkom procenom kod teškog bolesnika sa nejas-
nom dijagnozom.
Kljuÿne reÿi:
vegenerova granulomatoza; dijagnoza; purpura,
fulminantna; gastrointestinalne bolesti; histološke
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Introduction
Wegener granulomatosis (WG) is anti-neutrophil cyto-
plasmic antibodies (ANCAs)-associated systemic vasculitis of
small arteries and veins of unknown etiology. It is manifested
as granulomatous necrotizing inflammation of the respiratory
tract, glomerulonephritis and systemic vasculitis involving
most frequently the skin and oral mucous membrane. In the
lungs, paranasal sinuses and nasopharynx nodular infiltrates
can be found, with fever, weakness, sinus pain, or bloody or
purulent discharge from the nose, cough, hemoptysis and
dyspnoea. Skin lesions are found in 50% of patients; only 13%
with initial skin changes, usually on the legs: pyoderma gan-
grenosum-resembling lesions, papules, vesicles, palpable pur-
pura, subcutaneous nodules, plaques and noduloulcerous le-
sions resembling polyarteritis nodosa. Oral or nasal ulcers
and/or perforation of the nasal septum can be presented on
visible mucous membranes. The disease also affects the joints,
kidneys, eyes and central nervous system (CNS) 
1–4.
Case report
A female, aged 52 years, was admitted to the Clinic for
Dermatology, Military Medical Academy in Belgrade, with a
10 month history of purpuric spots on the lower legs. One
month before admission hemorrhagic bullae on the lower
extremities and hands, skin ulcers of the right lower leg and
thigh, abdomen and buttocks, hoarseness, dyspnea, general-
ized arthralgias, fatigue and fever up to 38°C had rapidly de-
veloped (Figures 1–4). By chest X-ray, performed few days
before admission, nodular infiltrates were observed. There
was a perforation of the nasal septum at the time of admis-
sion as seen by rhinoscopy. On the  third day of hospitaliza-
tion abdominal pain was reported. In laboratory analyses
elevation of nonspecific inflammatory factors was evident
[erythrocyte sedimentation rate (ESR) 63 mm/h, C-reactive
protein (CRP) 263 mg/L], with a significant leukocytosis
(33.2 × 10
9/L) and neutrophilia (93.5%). Other blood count
parameters, blood biochemistry, complement component 4
(C4) and liver enzymes serum activity were within normal
range. C3 was decreased (0.6 g/L). In urinalysis hemoglobin
and leukocytes were evident, with lot of sediment erythro-
cytes, leukocytes and bacteria, but urine culture was sterile,
such as blood culture was. Concentration of 24-h urine pro-
tein was slightly elevated: 0.234 g (upper limit 0.15 g).
ELISA human immunodeficiency virus (HIV), hepatitis B
surface antigen (HBsAg) and hepatitis C virus (HCV) tests
were negative. In peripheral blood smear increased number
of leukocytes was evident (55.7 × 10
9/L), as well as elevated
percentage of neutrophiles (95%). Immunologig analysis re-
vealed negative antinuclear antibodies (ANA) (HEp2 cell’s
substrate) and ENA screening tests, anticentromere antibod-
ies (ACA) were within the physiologic range, but ANCAs
were elevated (c-ANCA 18 IU/mL, p-ANCA 30 IU/mL). In
direct immunofluorescence (DIF) of purpuric papule speci-
men IgM deposits in the basement membrane zone, fine- and
coarse-grained deposits of C3 in the walls of blood vessels of
the dermis were found.
Fig. 1 – Hemorrhagic bullae on the back.
Fig. 2 – Hemorrhagic bullae on the hands and skin ulcers on
the right thigh.
Fig. 3 – Leg ulcers.
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Histopathologic examination of the purpuric papule re-
vealed necrotizing vasculitis of the skin (prominent extravas-
cular neutrophilia and foci of suppuration in the dermo-
subcutaneous border) (Figure 5). Histopathologic examina-
tion of nasal squamous mucosa revealed an acute inflamma-
tion. Ultrasound examination of the abdomen revealed di-
lated intestinal convolutions with proper findings on liver,
gallbladder, spleen and kidneys, but certain amount of asci-
tes. Esophagogastroduodenoscopy revealed ulceration on a
small curve diameter of 5 mm, the bottom covered with
white patches of scum from the edge dark crust (biopsy was
not performed). MSCT of the chest and abdomen revealed
right lung bullous formation of 2 cm in diameter at the top of
the upper lobe, a number of possible granulomas in the liver,
abdominal cavity was dominated by the free gas and the
presence of free intraabdominal fluid, with a finding on the
small bowel which may correspond to tumor formation or
small intestine curve in volvulus. Based on skin changes, na-
sal perforation and positive c- and p-ANCA, in consultation
with other specialists (rheumatologist, pulmologist, otolar-
yngologist) diagnosis of WG was established and the therapy
with a pulse dose of methylprednisolone (500 mg/d i.v., for 3
consecutive days) and 60 mg/d i.v. after pulse dose was ad-
ministred. Other therapy included: systemic antibiotics (met-
ronidazole, ciprofloxacine), analgesics, antipyretics, fluco-
nazole and pantoprazole gastroprotective therapy. Because of
a possible tumor in the small intestine revealed by MSCT
examination and the possible development of surgical abdo-
men (strong abdominal pain) exploratory laparotomy was
performed on the day 6 of hospitalization, in which a small
bowel perforation was found with diffuse peritonitis. Unsta-
ble in the postoperative period, the patient died on the day 12
of hospitalization due to peritonitis.
Discussion
In 1930s, Wegener described 3 patients in their 30s
with granulomatous vasculitis affecting the nose and throat,
lungs and kidneys. The syndrome became known as ‘Wege-
ner's granulomatosis 
1. Untill 1980s, the significance of the
association of c-ANCA with WG was not recognized. The
incidence of WG is estimated to be 5 to 12 cases per million,
with a slight female predominance 
2. Classic WG is the triad
of granulomatous inflammation of the upper and lower respi-
ratory tracts, systemic necrotizing small vessel vasculitis and
immune glomerulonephritis. Patients with classic WG have a
high mortality rate if left untreated, whereas patients with
limited forms have isolated features of the triad and less se-
vere involvement 
3. Mucocutaneous involvement occurs in
approximately 40% of patients with WG, and it can be the
presenting sign in 10% 
4. The most common lesions are pal-
pable purpura, followed by oral ulcers. Skin changes that re-
semble pyoderma gangrenosum can also be seen. The upper
or lower respiratory tracts are involved in up to 90% of pa-
tients with WG. Nasal involvement is responsible for pre-
senting complaints in greater than 70% of cases. Suggestive
symptoms and signs include recurrent epistaxis, mucosal ul-
cerations and nasal septal perforation. Patients with pulmo-
nary involvement present with dyspnea, cough, hemoptysis
or pleuritis, and chest X-rays demonstrate infiltrates or nod-
ules. Approximately 75% of patients eventually develop
glomerulonephritis 
5. Other organ systems commonly af-
fected in WG include musculoskeletal (70%), ocular (30–
60%), neurologic (20–50%) and gastrointestinal (5–10%).
Most common gastrointestinal manifestations include:
abdominal pain, nausea/vomiting, diarrhea, hematochezia or
melena. Elevated c-ANCA occurs in approximately 80% of
patients with classic or severe WG, but only in 60% of
patients with limited disease, and p-ANCA occurs in
approximately 10% of WG patients 
3. The majority of skin
biopsy specimens show nonspecific histopathologic changes,
but up to 50% demonstrate leukocytoclastic vasculitis and/or
granulomatous inflammation. The mainstay treatment for
patients with classic WG is systemic corticosteroids in
conjunction with cyclophosphamide, resulting in a remission
in up to 75% of patients 
5. In our patient, skin changes, nasal
septum perforation, small bowell perforation due to
vasculitis and occuring of ANCAs established the diagnosis
of WG. Lethal outcome occurred due to diffuse peritonitis.
Most common symptoms and signs of a small-vessel
vasculitis of the gastrointestinal tract are abdominal pain,
diarrhea and hematochezia. The frequency of gastrointestinal
manifestations in WG is actually uncertain, because of small
number of documented severe disease case reports 
6, 7. A
study involving 45 patients found abdominal symptoms in 4
of them 
6. Severe gastrointestinal involvement manifested
during the early stages of WG, particulary without
concomitant renal disease is very rare, just few cases were
previously reported, but without lethal outcome 
7, 8. In a
study of Pagnoux et al. 
9, presentation and outcome of
gastrointestinal (GI) involvement in systemic necrotizing
vasculitis were evaluated – a group of 62 patients with
systemic small and medium sized vessel vasculitis and GI
involvement: polyarteritis nodosa (total of 38), Churg Strauss
syndrome (total of 11), WG (total of 6), microscopic
polyangiitis (total of 4) and rheumatoid arthritis-associated
vasculitis (total of 3). GI manifestations were present at or
occured within 3 months of establishing diagnosis in 81% of
the patients: abdominal pain (97%), nausea or vomiting
(34%), diarrhea (27%) and hematochezia or melena (16%).
Fig. 5 – Histopathological finding of the purpuric papule –
prominent extravascular neutrophilia, and foci of suppura-
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Further, 34% patients devoloped surgical abdomen, 18%
peritonitis, 15% bowel perforation, 16% bowel ische-
mia/infarction and 6% intestinal occlusion. Peritonitis, bowel
perforations, GI ischemia/infarctions and intestinal occlusion
were the only GI manifestations significantly associated with
increased mortality (for this group of patients 6-month and 5-
year survival rates were 60% and 46%, respectively). But, in
the subgroup of WG patients none of severe GI manifesta-
tions related with increased mortality were evident. The most
severe manifestations in WG (total of 6) were esophageal
(total of 1), gastroduodenal (total of 2) and colorectal (total
of 2) ulcerations, without lethal outcome due to GI manifes-
tations.
Conclusion
Our patient showed severe gastrointestinal and skin
features, fulminant course and lethal outcome. This confirms
the necessity for rapid systemic clinical evaluation in any
critically ill patients with unclear diagnosis.
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